Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...

Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...

Neuralink just closed a hefty $650 million Series E round, pushing its valuation past the $9 billion mark. Backed by big names like ARK Invest, Founders Fund, Sequoia Capital, QIA and Valor Equity ...

Dementia experts have said that “hope is on the horizon” after a new review shows a rise in the number of potential drugs ...

Detailed data will be presented at a future medical meeting and submitted for regulatory review later this year.

In today’s environment, aligning the Target Product Profile with the appropriate Value Evidence Archetype is not just good ...

Neuralink closed its funding round with participation from key investors including ARK Invest, DFJ Growth, Founders Fund, G42 ...

Elon Musk’s brain-computer interface company, Neuralink, has secured $650 million in a fresh funding round as it moves ahead with ...

A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of ...

Neuralink accelerates its brain-computer interface ambitions with a major funding boost and ongoing human trials.

Zydus Lifesciences acquires India and Sri Lanka rights for Agenus' cancer immunotherapies BOT and BAL, aiming to expand ...

Neuralink, Elon Musk’s brain-computer interface (BCI) startup, raised US$650M in its latest Series E funding round.